Clinical Trial Update: Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease [Phase 4]

View source ↗

Summary

Phase 4 safety study evaluating topical cyclosporine for dry eye disease, involving patients with Sjögren-related dry eye.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aqueous Deficient Dry Eye Disease
• Evaporative Dry Eye Disease
• Sjogren Syndrome

Drugs mentioned

• Topical Cyclosporine (cyclosporine ophthalmic)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Primary Sjogren Syndrome, Secondary Sjogren Syndrome | Phase 4 | Status: COMPLETED